| Authors: |
Gerhards J; Section of Pharmacogenomics, Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Eberhard-Karls-University Tübingen, Tübingen, Germany., Maerz LD; Institute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany., Matthees ESF; Institute for Molecular Cell Biology, University Hospital Jena, Friedrich-Schiller University of Jena, Jena, Germany., Donow C; Institute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany., Moepps B; Institute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany., Premont RT; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Burkhalter MD; Section of Pharmacogenomics, Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Eberhard-Karls-University Tübingen, Tübingen, Germany., Hoffmann C; Institute for Molecular Cell Biology, University Hospital Jena, Friedrich-Schiller University of Jena, Jena, Germany., Philipp M; Section of Pharmacogenomics, Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Eberhard-Karls-University Tübingen, Tübingen, Germany. |
